BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24654231)

  • 1. A meta-analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma.
    Chen R; Khatri P; Mazur PK; Polin M; Zheng Y; Vaka D; Hoang CD; Shrager J; Xu Y; Vicent S; Butte AJ; Sweet-Cordero EA
    Cancer Res; 2014 May; 74(10):2892-902. PubMed ID: 24654231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTK7 expression is associated with lymph node metastasis, ALK and EGFR mutations in lung adenocarcinomas.
    Jiang W; He J; Lv B; Xi X; He G; He J
    Histol Histopathol; 2020 May; 35(5):489-495. PubMed ID: 31701509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein tyrosine kinase 7 plays a tumor suppressor role by inhibiting ERK and AKT phosphorylation in lung cancer.
    Kim JH; Kwon J; Lee HW; Kang MC; Yoon HJ; Lee ST; Park JH
    Oncol Rep; 2014 Jun; 31(6):2708-12. PubMed ID: 24789704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.
    Lhoumeau AC; Martinez S; Boher JM; Monges G; Castellano R; Goubard A; Doremus M; Poizat F; Lelong B; de Chaisemartin C; Bardin F; Viens P; Raoul JL; Prebet T; Aurrand-Lions M; Borg JP; Gonçalves A
    PLoS One; 2015; 10(5):e0123768. PubMed ID: 25962058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.
    Jacobson O; Weiss ID; Wang L; Wang Z; Yang X; Dewhurst A; Ma Y; Zhu G; Niu G; Kiesewetter DO; Vasdev N; Liang SH; Chen X
    J Nucl Med; 2015 Nov; 56(11):1780-1785. PubMed ID: 26315836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions.
    Damelin M; Bankovich A; Bernstein J; Lucas J; Chen L; Williams S; Park A; Aguilar J; Ernstoff E; Charati M; Dushin R; Aujay M; Lee C; Ramoth H; Milton M; Hampl J; Lazetic S; Pulito V; Rosfjord E; Sun Y; King L; Barletta F; Betts A; Guffroy M; Falahatpisheh H; O'Donnell CJ; Stull R; Pysz M; Escarpe P; Liu D; Foord O; Gerber HP; Sapra P; Dylla SJ
    Sci Transl Med; 2017 Jan; 9(372):. PubMed ID: 28077676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement.
    Gärtner S; Gunesch A; Knyazeva T; Wolf P; Högel B; Eiermann W; Ullrich A; Knyazev P; Ataseven B
    PLoS One; 2014; 9(1):e84472. PubMed ID: 24409301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma.
    Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL
    Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies.
    Jie Y; Liu G; Feng L; Li Y; E M; Wu L; Li Y; Rong G; Li Y; Wei H; Gu A
    Front Immunol; 2021; 12():665970. PubMed ID: 34475869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Increased PTK7 Expression Is a Malignant Factor in Cervical Cancer.
    Sun JJ; Li HL; Guo SJ; Ma H; Liu SJ; Liu D; Xue FX
    Dis Markers; 2019; 2019():5380197. PubMed ID: 30944666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma.
    Jin J; Ryu HS; Lee KB; Jang JJ
    PLoS One; 2014; 9(2):e90247. PubMed ID: 24587299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organization of the human PTK7 gene encoding a receptor protein tyrosine kinase-like molecule and alternative splicing of its mRNA.
    Jung JW; Ji AR; Lee J; Kim UJ; Lee ST
    Biochim Biophys Acta; 2002 Dec; 1579(2-3):153-63. PubMed ID: 12427550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of PTK7 in colon cancer cells: caspase-10-dependent apoptosis via mitochondrial pathway.
    Meng L; Sefah K; O'Donoghue MB; Zhu G; Shangguan D; Noorali A; Chen Y; Zhou L; Tan W
    PLoS One; 2010 Nov; 5(11):e14018. PubMed ID: 21103379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma.
    Shin WS; Gim J; Won S; Lee ST
    Sci Rep; 2018 Jun; 8(1):8519. PubMed ID: 29867084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of PTK7 as a promising therapeutic target for thyroid cancer.
    Duan F; Tang J; Kong FL; Zou HW; Ni BL; Yu JC
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6809-6817. PubMed ID: 32633373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma.
    Shin WS; Kwon J; Lee HW; Kang MC; Na HW; Lee ST; Park JH
    Cancer Sci; 2013 Aug; 104(8):1120-6. PubMed ID: 23663482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of oncogenic point mutations and hyperphosphorylation of anaplastic lymphoma kinase in lung cancer.
    Wang YW; Tu PH; Lin KT; Lin SC; Ko JY; Jou YS
    Neoplasia; 2011 Aug; 13(8):704-15. PubMed ID: 21847362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of oncogenic protein kinase Ciota signaling in lung adenocarcinoma.
    Erdogan E; Klee EW; Thompson EA; Fields AP
    Clin Cancer Res; 2009 Mar; 15(5):1527-33. PubMed ID: 19223491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.
    Kwon OS; Oh E; Park JR; Lee JS; Bae GY; Koo JH; Kim H; Choi YL; Choi YS; Kim J; Cha HJ
    Oncotarget; 2015 Dec; 6(39):41916-28. PubMed ID: 26544896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer.
    Yu J; Bulk E; Ji P; Hascher A; Tang M; Metzger R; Marra A; Serve H; Berdel WE; Wiewroth R; Koschmieder S; Müller-Tidow C
    Clin Cancer Res; 2010 Apr; 16(8):2275-83. PubMed ID: 20371680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.